It's been an eventful couple of weeks in terms of IACP's legislative and regulatory priorities.

 

For one thing, our bill to clarify the compounding provisions of DQSA was reintroduced (read about it below).  For another, we issued a call-to-action to our members, urging you to reach out to your members of Congress to encourage them to sign-on to a congressional letter asking FDA to make adjustments to the state MOU they've circulated (read about that below, too).

 

And lastly, we began an effort to redeem more than 1300 lapsed IACP members who, for one reason or another, have dropped their membership over the past five years. "What does that have to do with our legislative and regulatory priorities?" you may ask. Answer: Everything.   The stronger we are, the more voices we add to the call for Congress and FDA to act to protect patient access to compounded medications, the more effective we can be in getting the job done.

 

We definitely NEED those former members - but not only those former members. We also need the members of your compounding team - pharmacists and technicians alike - who are not IACP members to join IACP. As a part of IACP, they're stronger than they are on their own, and our influence will be stronger when they are a part of us.

 

Read on to learn about our legislation and the congressional MOU letter. But I hope you'll also encourage those on your team who aren't part of IACP to join.   They can do so online here  or they can call (281) 933-8400 to do it by phone.

 

Looking forward to seeing you at Compounders on Capitol Hill in Washington, DC in a few weeks.  You can read more about that opportunity below, too!

We're six weeks away from CCH. Where are you?

If you've already registered, thank you. If you haven't, GET GOING! We need you...

Come to Washington, DC, May 18-21 and help us move the ball on our DQSA-clarifying legislation.

 

Compounders on Capitol Hill  is your once-a-year opportunity to join with fellow compounding pharmacy owners from across America to tell members of Congress about the effects of regulatory overreach on your patients and the real value you provide in helping those patients live healthier lives. And this year, our priority is clear: Gather additional co-sponsors for H.R. 1959, which would clarify DQSA's compounding provisions to assure your patients can continue to access compounded meds and you can continue to serve their needs.

 

When you invest time and money to travel to DC to meet with your members of Congress on their turf, they take notice. They listen. And we get things done for compounding.

 

   

(Don't forget to book your room at the Renaissance Washington at the  discounted CCH room rate of $229 . And hurry! Our room block will be full before you know it ...)

 

ALSO: We've added two great panel discussions to the conference agenda ...